Design and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial on the cardiovascular effects of dulaglutide
on behalf of the REWIND Trial Investigators
Research output: Articles / Notes › Scientific Article › peer-review
143Scopus
citations
Fingerprint
Dive into the research topics of 'Design and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial on the cardiovascular effects of dulaglutide'. Together they form a unique fingerprint.